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Abstract 
Captopril short elimination half-life (2-3 hours) and good stability at pH 1,2 with its major 
absorption in the upper part of Gastro Intestinal Tract (GIT) was the reason of this drug 
formulated into sustained release floating tablets.  This research was conducted in order to 
obtain several formulations and evaluate the physical characteristics, floating lag time and 
dissolution rate of the floating tablets. The captopril floating tablets were produced by 
direct compression technique using combination of polymers (HPMC, ethyl cellulose and 
CMC-Na in different concentrations). The gel forming agent, gas generating agent and 
another polymer were used to control their floating capability and drug dissolution rate 
profile. The tablet floating capability was evaluated by determining lag time and floating 
duration. All formulas remained buoyant for more than 12 hours. The drug release 
evaluated for 12 hours using USP paddle-type II dissolution apparatus in a 900ml 0,1N 
HCl as dissolution medium. The dissolution efficiency of control tablets (Formula 1) was 
90,98%. There was a significance difference compared to dissolution efficiency value of 
Formula 2 (2% CMC-Na), Formula 3 (4% CMC-Na), Formula 4 (6% CMC-Na), Formula 
5 (10% Ethyl cellulose), Formula 6 (20% Ethyl cellulose), Formula 7 (30% Ethyl 
cellulose) as 86,35%, 83,88%, 80,35%, 81.25%, 75.81%, and 78.16%,  respectively. The 
result of this research indicates that tablet formulation with different in composition of the 
polymers (CMC-Na and Ethyl cellulose) affects the floating capability and dissolution rate 
of the tablets, which is important in consider floating tablet as captopril sustained release 
delivery system. 
 
Keywords: captopril, HPMC, CMC-Na, ethyl cellulose, floating tablet, sustained release 
 
1. INTRODUCTION 
 
The conventional tablets commonly used today have its limitations. The limitations of 
conventional tablets are on fluctuations in drug plasma concentrations (Brahmankar & 
Jaiswal, 2009). Controlled release tablets made to answer that limitations, because of the 
use of controlled release tablets can avoid fluctuations of drug levels in plasma. Controlled 
release tablets also used to improve the patient with chronic diseases compliance in taking 
the drug (Kumar, 2012). The use of controlled release tablet still has limitations, where the 
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controlled release tablet that has been designed could not survive in the absorption place 
during the drug release from the matrix (Prinderre et al., 2011). 
The way to make controlled release dosage forms can survive in the gastrointestinal tract is 
by using the Gastro Retentive Drug Delivery System (GRDDS) (Chikhalikar & Wakade, 
2012). Drugs that require GRDDS work locally in the gut, mostly absorbed in the gastric, 
insoluble in an alkaline pH, and drugs that unstable at alkaline pH (Mishra & Gupta, 2012). 
One example of a drug that is absorbed in the stomach and degraded at an alkaline pH is 
captopril (Sweetman 2011; Vijayasankar et al., 2011). 
 
Floating drug delivery system is GRDDS dosage form that has smaller density than gastric 
fluid, so that it can float on the top of the gastric juices and is not influenced by the gastric 
emptying time (Narang, 2011). Materials such as HPMC in floating system are used as 
gelling materials and swelling agents. Swollen HPMC then locks the air inside and shows 
floating effect of the systems (Mishra & Gupta, 2012). In this experiment, ethyl cellulose 
and CMC-Na as polymers can protect the penetration of medium, lowering the floating lag 
time, and improve floating duration (Dhole et al., 2011; Chowdary et al., 2013). 
 
The floating ability and dissolution profiles will be tested in this research based on percent 
dissolved, dissolution efficiency and floating duration of 7 kinds of formulas with different 
ethyl cellulose and CMC Na composition in each formula. It is expected that the formula 
can provide buoyancy and good dissolution profiles at pH 1, 2 for 12 hours. 
 
 
2. MATERIALS AND METHODS 
 
2.1 Equipments 
Erweka AR 402 tablet compression machine, Monsato hardness tester, Pharmex Y cone 
mixer, Hanson Research SR-8 dissolution apparatus, Sartorius BP10 analytical balance, 
Erweka friability tester, Shimadzu spektrofotometer. 
 
2.2 Material 
Captopril p.g (Huahai), HPMC K100M p.g (Colorcon), ethyl cellulose p.g (Colorcon), 
spray dried lactose p.g (Foremost), NaHCO3 (Inner Mongolia Ihjuchen), citric acid 
(Anugrah Buana), magnesium stearate p.g (Bratachem), HCl p.a (Sigma). 
 
2.3 Method 
2.3.1 Tablets Formulation 
The process of producing the tablet was done by direct compression method. The powder 
mixture was made by mixing of captopril, HPMC K100M, ethyl cellulose, CMC Na, SDL, 
NaHCO3 and citric acid. Mixed mixture was screened by siever. Magnesium stearate then 
added and mixed to form the 240mg weight tablets. 
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Table 1 Floating Tablet Formula 
Materials 
Weight (mg) 
F1 
(control) 
F2 F3 F4 F5 F6 F7 
Captopril 25 25 25 25 25 25 25 
HPMC K100M 48 48 48 48 48 48 48 
CMC- Na - 4,8 9,6 14,4 - - - 
Etil Selulosa - - - - 24 48 72 
Mg. Stearat 1,2 1,2 1,2 1,2 1,2 1,2 1,2 
SDL (Spray 
Dried Lactose) 
ad 240 ad 240 ad 240 ad 240 ad 240 ad 240 ad 240 
 
2.3.2 Powder Mixture Evaluation  
The moisture content of the powder is tested by weighing it for 5 grams and checked it in 
the moisture content balance. Drying will take place until it showed no change of material 
weight. Good moisture content value was 1-4%. Compressibility also tested with a number 
of material in the tap density volumenometer. The density of material before and after 
tapping process was determined and calculated to get the compressibility value. Powder 
good compressibility value was <20% (US Pharmacopoeial Convention ., 2017).  
 
2.4 Tablet Evaluation  
2.4.1 Physical Characteristics of Tablets 
Tablet weight variation is measured by weighing one by one of 10 tablets with analytical 
balance. Weight variation data is quite good, if the acceptance value is not more than 15% 
(US Pharmacopoeial Convention ., 2017). Tablet hardness was measured with 10 tablets 
prepared. The tablet to be tested is placed on Monsanto hardness tester. The tool base 
rotated until the tablet breaks and the scale was read that indicates the numbers of tablet 
hardness. In the tablet hardness testing all tablets should be crushed by the load 4,0 to 8,0 
kg (Lieberman et al., 1990). 
 
Tablet friability was measured from 20 tablets prepared, then weighed and included in the 
test apparatus. After rotated, the tablet is then removed and then weighed again. It said to 
be good if the weight loss is not more than 1% (Lieberman et al., 1990). 
 
2.4.2 Content Uniformity of Tablets 
Preparation of captopril standart solution performed by weighing 50,0 mg captopril, then 
dissolved in 0,01N HCl until 50,0 ml. The standard solution then prepared into several 
working standart Maximum wavelength were observed  between 200-300 nm using a UV 
spectrophotometer. Standard curve obtained from observations of absorption value of the 
standard solution at each concentration of captopril was observed at maximum wavelength. 
(Vijayasankar et al., 2011; Mehta et al., 2011). 
 
Captopril content uniformity in tabletis measured by weighted 10 tablets are taken 
randomly and ground into powder. Powder weighed equal with 25 mg captopril and diluted 
to 100,0ml. The solution was filtered using Whatmann filter paper (0,45 µm). Dilution was 
observed using a UV spectrophotometer at maximum wavelength (Vijayasankar et al., 
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2011) (Mehta et al., 2011). 
 
2.4.3 Floating Lag Time and Floating Duration 
Floating lag time and floating duration time test was done with Measure Glass equipment, 
heater, thermometer and stop watch. 200ml 0,01N HCl solution putted into a measuring 
cup 250 ml in temperature of 37
o
C, then the tablet was inserted. Floating lag time was 
observed. The time required for the tablet to rise up to the surface and begin to float on the 
medium surface is recorded as floating lag time, while the time for the tablet remains 
constant on the dissolution media surface is recorded as floating duration time. Floating 
duration time was expected to be not less than 12 hours to be able to ensure the drug is in 
the stomach within 12 hours (Vijasankar et al., 2011). 
 
2.4.4 Dissolution Test 
The dissolution media used were 900ml 0,01N HCl solution (pH 1.2) and using a type II 
dissolution apparatus 50rpm. Temperature and time for dissolution test were 37 ± 0.5 
0
 C 
for 12 hours. Sampling was done at 60, 120, 180, 240, 300, 360, 420, 480, 540, 600, 660, 
720 minutes. Measurements performed with a UV spectrophotometer at the maximum 
wavelength (US Pharmacopoeial Convention., 2017) (Vijayasankar et al., 2011) (Mehta et 
al., 2011). The drug release profile of captopril is accomplished by making the captopril 
released curve (% Q) per time. Dissolution profile curves calculated from AUC (Area 
Under the Curve) to determine the efficiency of dissolution. The results obtained were 
floating lag time, floating duration, percent of dissolution efficiency (%ED), percent 
dissolved (%Q) then analyzed using statistical methods to determine whether there were 
significant differences between the groups were tested.  
 
3. RESULTS AND DISCUSSION 
Materials were mixed into homogenous mixture. Before compressed into tablet, the 
powder mixture was tested first. The mixture showed good result in compressibility and 
moisture content, then it continued with compression using direct compression method. 
 
Table 2. Characteristics of powder mixture 
Formula Compressibility (%) Moisture content 
(%) 
F1 12.00% 1.96% 
F2 13,16% 2,04% 
F3 12,82% 1,98% 
F4 13,16% 2,08% 
F5 14.29% 1.98% 
F6 13.64% 1.72% 
F7 14.63% 1.50% 
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Table 3. Physical Characteristics of Tablets 
Evaluation F1 
(control) 
F2 F3 F4 F5 F6 F7 
Weight 
variation 
(mg) 
244,54 
± 1,18 
240,56 
± 0,59 
243,80 
± 0,77 
244,66 
± 0,91 
243,21 ± 
1,05 
242,27 ± 
0,94 
240,87 ± 
0,76 
Tablet 
Hardness 
(kg) 
7,00 ± 
0,41 
5,50 ± 
0,53 
5,20 ± 
0,26 
5,15 ± 
0,24 
5,05 ± 
0,28 
4,50 ± 
0,33 
4,20 ± 
0,24 
Tablet 
Friability 
(%) 
0,16 ± 
0,06 
0,18 ± 
0,08 
0,18 ± 
0,10 
0,18 ± 
0,06 
0,12 ± 
0,07 
0,16 ± 
0,05 
0,09 ± 
0,06 
Floating 
Lag time 
(sec) 
16,33 ± 
0,57 
16,67 ± 
0,58 
17,00 ± 
1,00 
17,33 ± 
0,58 
19,67 ± 
1,00 
24,67 ± 
1,15 
32,33 ± 
2,52 
Uniformity 
of content 
(%) 
105,30 
± 0,67 
 
105,01 
± 0,10 
104,35 
± 0,46 
104,16 
± 0,52 
104,64 ± 
0,72 
109,55 ± 
0,96 
103,33 ± 
0,47 
 
Based on evaluation results, shown that all of formula had good physical characteristics. 
The results determined that tablets weight variation, hardness and friability of all formula 
met the requirements. Floating duration results showed the entire formula could float for 
more than 12 hours. Floating lag time of each formula was different, according to the 
amount of polymer. Addition of CMC-Na was not very influences the floating lag time, 
but it became statistically influences when ethyl cellulose added into components of 
formula, provided longer floating lag time. This floating resistance could be caused by the 
ethyl cellulose properties as a hydrophobic polymer that inhibits penetration of the 
medium into the tablet, so it takes longer time for HPMC K100M to expand and form a 
system that can make the tablet floated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Dissolution rate of Captopril 
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The dissolution test results showed the release resistance on the addition of CMC-Na and 
ethyl cellulose in the formula. This results showed that the addition of CMC-Na and ethyl 
cellulose in the formula could decrease the dissolution efficiency, where the decrease in 
%ED indicates a decrease in the dissolution rate, but on increasing the ethyl cellulose 
concentration from 10% to 30% did not indicate a significant %ED change.   
 
Table 4. Dissolution Efficiency Results 
Formula Dissolution 
Efficiency (%) 
F1 90,98 ± 0,47 
F2 86,35 ± 2,48 
F3 83,88 ± 6,82 
F4 80,35 ± 1,32 
F5 81,25 ± 3,50 
F6 75,81 ± 0,98 
F7 78,16 ± 0,72 
 
 
4. CONCLUSIONS 
The ethyl cellulose and CMC-Na use as polymer showed the influence on controlled 
release floating tablet result. The addition of ethyl cellulose and CMC-Na reduced the 
dissolution rate, and showed the sustained release profile of captopril. Addition of ethyl 
cellulose and CMC-Na affected the floating lag time, significantly made it slower based on 
higher concentration of the polymer. The differences could be influenced by improvement 
of viscosity surrounds the tablets. Amount of ethyl cellulose and CMC-Na must be 
considered, also the possibility on using both of polymer as combination to get faster 
floating lag time, longer floating duration and sustained release effect on captopril. 
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